Listen Score
LS 25
Global Rank
TOP 10%

MENGENAI PODCAST INI 🔗

Kekerapan kemas kini:
monthly
Purata panjang audio:
30 minutes
Temu bual tetamu
Bahasa Inggeris
Amerika Syarikat
28 episod
sejak 13 Nov 2023
episodic

EPISOD TERKINI 🔗

In this episode, Surani explores the unconventional start-up story of Infinimmune, an antibody discovery company founded in 2022 by five former 10x Genomics scientists. Starting with a scientific hunch that advances in single-cell sequencing were revealing previously overlooked antibody biology ...

CARI EPISOD LEPAS

Cari episod lepas bagi Raising Biotech .

EPISOD SEBELUMNYA

In this July summer episode, we slow things down again and revisit a conversation from the Raising Biotech archive. Today's episode is a replay from November 2023, featuring Synchron, a company developing implantable brain-computer interfaces (BCIs) to restore communication and digital independ ...
In this special Investor Spotlight edition of Raising Biotech, Surani sits down with Dr. Jakob Dupont, Executive Partner at Sofinnova Investments, to explore one of the most unusual career trajectories in biotech. Before becoming a venture investor, Dupont spent decades as a physician, cancer re ...
In this episode, Surani explores one of biotech’s most controversial and ambitious frontiers: psychedelic medicine. At the center of the story is Compass Pathways, the London-based biotech attempting to bring synthetic psilocybin through the modern drug approval system for treatment-resistant ...
In this episode, Surani takes a deep dive with experts into biotechs hottest new hype cycle -- GLP-1s. Over the past couple years, biotech investing has felt like it’s entering a new gravitational field, with GLP-1s at the center. Once a niche diabetes therapy, these drugs have evolved into a co ...
In this episode, Surani speaks with George Magrath, CEO of Opus Genetics, about the realities of leading a public biotech company through a major strategic pivot and intense market scrutiny. Opus Genetics emerged from a 2024 reverse merger between Nasdaq-listed Ocuphire Pharma and a private gene ...
In this episode, we focus on the personal journey of Sheila Gujrathi, a physician turned biotech builder whose career spans medicine, big pharma, rapid IPOs, and billion dollar exits. We explore what it takes to raise biotech across cycles, from early clinical development to public markets, and ...
In this early-January episode, we slow things down, and reflect... Today’s episode is a replay from the Raising Biotech archive — a conversation originally recorded in November 2023 with eGenesis, a company working at the frontier of xenotransplantation, or transplanting genetically modifie ...
In this episode, we dive into one of the most universal aesthetic concerns on the planet: pattern hair loss. Despite affecting more than 80 million people in the US and over a billion globally, innovations in treatment have barely moved in decades. Veradermics is aiming to change that with an ex ...
In this special on-the-ground episode of Raising Biotech, Surani takes you inside BIO-Europe 2025 in Vienna — the dealmaking, the caffeine, and the cautious optimism shaping Europe’s biotech landscape right now. Over three packed days, 6,000+ attendees from more than 60 countries gathered to b ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Surani Fernando, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.